Moderna: a bounce that doesn't convince
Moderna stock: 1.4% rebound, but sellers seize back control
Moderna: a bounce that doesn't convince
Our view last week
Moderna shares book a second heavy week, down 12.5% in five days, and this time the model's Sell signal switches on. Price carved a double bottom in the 53 area with a 66% intermediate rebound, but the last bar saw sellers come back in extreme force. Signal strength climbs to 100 out of 100: the decline is making lower lows, pace holding. Weekly technical analysis as earnings land this very week.
This week's summary
After last week's 12.5% plunge, Moderna shares tried a 1.4% bounce, but sellers came back to dominate the final bar and buyers are in retreat: the rebound carries little conviction. Signal strength reads a decline losing steam, and earnings land today, with volatility already elevated. Weekly technical analysis of the fresh Sell signal, now in its second week.
Sell signal in observation
·2nd week from start
·US stocks
·T2
·📅 Earnings · Jul 31
★ See Gold version →
IQS Phase
76
in tension
Signal Strength
39
decline losing steam
Sizing
REDUCED
Ranking
#23 / 138
US stocks sell signals
Trade P&L %
-1.39%
from signal to date, no stop loss
Rank position
ranks 23rd among the 138 sell signals for US stocks in our ranking, with a signal strength of 39 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
MRNA belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content